Funding for this research was provided by:
National Health and Medical Research Council (393703)
Cancer Council Western Australia (APP1021376)
Cancer and Palliative Care Research and Evaluation Unit (SCG12/001)
Text and Data Mining valid from 2018-04-13
Received: 30 August 2017
Accepted: 13 March 2018
First Online: 13 April 2018
Ethics approval and consent to participate
: This research was conducted as a sub-study of the TARGIT-A Trial (ISRCTN - 34,086,741). Ethical and institutional approval was granted to all participating sites prior to commencement of patient recruitment (Lead Ethics Committee: Sir Charles Gairdner Hospital, Reference 2003–108). Patients were required to provide written informed consent to participate in this research.
: Not Applicable
: DJ received a research grant from Photoelectron Corp in 2001 to support data management. JSV received a research grant from Photoelectron Corp (1996–99) and from Carl Zeiss for supporting data management at the University of Dundee (Dundee, UK) and has subsequently received honoraria. MB was on the scientific advisory board of Carl Zeiss and was paid monthly consultancy fees until 2010. Carl Zeiss sponsored some of the travel and accommodation for meetings of the international steering committee and when necessary for conferences where a presentation about targeted intraoperative radiotherapy is being made for all authors apart from AN and MT. Carl Zeiss had no involvement in this publication.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.